Unknown statusInterventionalPhase 4Updated Aug 29, 2014
The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension | NCT02156024 | Trialant
Unknown statusInterventionalPhase 4Updated Jun 6, 2014
The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
ClinicalTrials.gov ID
NCT02156024
Lead Sponsor
Shanghai Institute of HypertensionOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Phase 4
Enrollment
400Estimated
Last Update Posted
Jun 6, 2014Estimated
Start Date
Mar 2014
Primary Completion Date
Mar 2015Estimated
Brief Summary
The purpose of this study is
To determine whether the Gastrodia and Uncaria Drink is effective in the treatment of masked hypertensive patients below 70 years.
To find out the suitable groups for the Gastrodia and Uncaria Drink treatment.
Masked Hypertension
Gastrodia and Uncaria Drink
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age between 18 to 70 years
didn't use any anti-hypertension drugs within 2 weeks
stage 1 masked hypertensive patients, which means clinic blood pressure<140/90 mmHg,however the daytime(8:00-18:00) 24h ambulatory blood pressure between 135/85 and 150/95mmHg
be willing to participate in the trials and able to finish clinic visit
Exclusion Criteria:
secondary hypertension
be allergic to the clinical trial medicine
occurrence of stroke, CKD, myocardial infarction within 2 years
dysfunction of liver or kidney and fundus hemorrhage
arrhythmia
ALT, AST, TBL upper the twice of normal range, Scr≥2.0mg/dl, K+≥5.5mmol/L, Urine protein≥2+
psychiatric disorders
pregnant, breastfeeding
other serious conditions in which is not fit for the study